University of California San Francisco
Give to UCSF
Esteban Burchard, who arrived at UCSF in 1998, marks the 20th year of his asthma project in May. His lab, which he named the UCSF Asthma Collaboratory, has delved deep into the genetic basis of asthma and of drug response in the disease.
Automated breast-density evaluation was just as accurate in predicting women’s risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists.
New study could make it much easier for physicians to use the genetic profile of a patient’s tumor to pick the chemotherapy treatment with the fewest side effects and best chance of success.
Early child care does not boost children’s risk for developing asthma.
Ata's appearance can most likely be explained by a handful of rare genetic mutations—some already known, others newly discovered—that are linked to dwarfism and other bone and growth disorders.
The largest-ever whole-genome sequencing study of drug response in minority children has revealed new clues about why the front-line asthma drug albuterol does not work as well for minority children.
UCSF received more than $593.9 million in federal funding from the National Institutes of Health in 2017 for research across multiple health-science arenas at the University.
Adolescents who smoke e-cigarettes are exposed to significant levels of potentially cancer-causing chemicals also found in tobacco cigarettes, even when the e-cigarettes do not contain nicotine.
A UCSF research team has found that while banning flame-retardant chemicals initially led to a reduction in exposure, a disturbing trend is emerging of exposure leveling off or even rising again.
Type 2 diabetes is known to be a risk factor for bone fractures – but exactly how diabetes makes bones more fragile has been unclear.
